Cirrhosis, von Willebrand Factor (vWF) and the Low Incidence of Metastatic Malignancy in Injured Liver

Por Alonso, Daniel F.
Publicado no Eurasian J Med (2015)

AZT as a telomerase inhibitor

Por Gomez, Daniel E., Armando, Romina G., Alonso, Daniel F.
Publicado em 2012

Cancer Antigen Prioritization: A Road Map to Work in Defining Vaccines Against Specific Targets. A Point of View

Por Gomez, Daniel E., Vázquez, Ana María, Alonso, Daniel F.
Publicado em 2012

Anti-idiotype antibodies in cancer treatment

Por Gomez, Daniel E., Vázquez, Ana M., Alonso, Daniel F., Macías, Amparo
Publicado em 2013

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

Por Alonso Daniel F, Gomez Daniel E, Otero Laura L, Gabri Mariano R
Publicado em 2009-12-01

Exogenous incorporation of neugc-rich mucin augments n-glycolyl sialic acid content and promotes malignant phenotype in mouse tumor cell lines

Por Gabri, Mariano R, Otero, Laura L, Gomez, Daniel E, Alonso, Daniel F
Publicado em 2009

Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System

Por Blanco, Rancés, Rengifo, Enrique, Cedeño, Mercedes, Rengifo, Charles E., Alonso, Daniel F., Carr, Adriana
Publicado em 2011

Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor Cells

Por Pifano, Marina, Garona, Juan, Capobianco, Carla S., Gonzalez, Nazareno, Alonso, Daniel F., Ripoll, Giselle V.
Publicado no Front Oncol (2017)

Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell l...

Por Segatori, Valeria I., Vazquez, Ana M., Gomez, Daniel E., Gabri, Mariano R., Alonso, Daniel F.
Publicado em 2012

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model

Por Ripoll, Giselle V., Garona, Juan, Pifano, Marina, Farina, Hernan G., Gomez, Daniel E., Alonso, Daniel F.
Publicado em 2013

Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3

Por Guthmann, Marcelo D., Venier, Cecilia, Toledo, Darien, Segatori, Valeria I., Alonso, Daniel F., Fainboim, Leonardo, Vázquez, Ana M., Ostrowski, Hector
Publicado em 2013

Telomere structure and telomerase in health and disease

Por GOMEZ, DANIEL E., ARMANDO, ROMINA G., FARINA, HERNÁN G., MENNA, PABLO LORENZANO, CERRUDO, CAROLINA S., GHIRINGHELLI, P. DANIEL, ALONSO, DANIEL F.
Publicado em 2012

NGcGM3 Ganglioside: A Privileged Target for Cancer Vaccines

Por Fernandez, Luis E., Gabri, Mariano R., Guthmann, Marcelo D., Gomez, Roberto E., Gold, Silvia, Fainboim, Leonardo, Gomez, Daniel E., Alonso, Daniel F.
Publicado em 2010

Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides – preclinical and clinical data

Por Vázquez, Ana M., Hernández, Ana M., Macías, Amparo, Montero, Enrique, Gómez, Daniel E., Alonso, Daniel F., Gabri, Mariano R., Gómez, Roberto E.
Publicado em 2012

Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells

Por Cardama, Georgina A, Gonzalez, Nazareno, Ciarlantini, Matias, Gandolfi Donadío, Lucia, Comin, María Julieta, Alonso, Daniel F, Menna, Pablo Lorenzano, Gomez, Daniel E
Publicado no Onco Targets Ther (2014)

Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines

Por Cardama, Georgina A, Comin, Maria J, Hornos, Leandro, Gonzalez, Nazareno, Defelipe, Lucas, Turjanski, Adrian G, Alonso, Daniel F, Gomez, Daniel E, Menna, Pablo Lorenzano
Publicado em 2014

The Functional Interaction between Acyl-CoA Synthetase 4, 5-Lipooxygenase and Cyclooxygenase-2 Controls Tumor Growth: A Novel Therapeutic Target

Por Orlando, Ulises D., Garona, Juan, Ripoll, Giselle V., Maloberti, Paula M., Solano, Ángela R., Avagnina, Alejandra, Gomez, Daniel E., Alonso, Daniel F., Podestá, Ernesto J.
Publicado em 2012

The novel desmopressin analogue [V(4)Q(5)]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models

Por GARONA, JUAN, PIFANO, MARINA, ORLANDO, ULISES D., PASTRIAN, MARIA B., IANNUCCI, NANCY B., ORTEGA, HUGO H., PODESTA, ERNESTO J., GOMEZ, DANIEL E., RIPOLL, GISELLE V., ALONSO, DANIEL F.
Publicado no Int J Oncol (2015)

Detection of N-Glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: An Attractive Vaccine Target for Aggressive Pediatric Cancer

Por Scursoni, Alejandra M., Galluzzo, Laura, Camarero, Sandra, Lopez, Jessica, Lubieniecki, Fabiana, Sampor, Claudia, Segatori, Valeria I., Gabri, Mariano R., Alonso, Daniel F., Chantada, Guillermo, de Dávila, María Teresa G.
Publicado em 2011

Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

Por Solares, Ana M, Santana, Agueda, Baladrón, Idania, Valenzuela, Carmen, González, Carlos A, Díaz, Alina, Castillo, Dagnelia, Ramos, Thelvia, Gómez, Roberto, Alonso, Daniel F, Herrera, Luis, Sigman, Hugo, Perea, Silvio E, Acevedo, Boris E, López-Saura, Pedro
Publicado em 2009